Controlling long-term SARS-CoV-2 infections is important for slowing viral evolution

Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Diane Joseph-McCarthy, Arijit Chakravarty
doi: https://doi.org/10.1101/2021.04.10.21255251

Article Information

doi 
https://doi.org/10.1101/2021.04.10.21255251
History 
  • April 17, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Debra Van Egeren1,2,3,
  2. Alexander Novokhodko4,
  3. Madison Stoddard5,
  4. Uyen Tran5,
  5. Diane Joseph-McCarthy6 and
  6. Arijit Chakravarty5,*
  1. 1Harvard Medical School, Boston, MA, USA
  2. 2Dana-Farber Cancer Institute, Boston, MA, USA
  3. 3Boston Children’s Hospital, Boston, MA, USA
  4. 4University of Washington, Seattle, WA, USA
  5. 5Fractal Therapeutics, Cambridge, MA, USA
  6. 6Boston University, Boston, MA, USA
  1. ↵*Corresponding author; email: arijit{at}fractaltx.com
Back to top
Posted April 17, 2021.
Download PDF
Data/Code
Email
Controlling long-term SARS-CoV-2 infections is important for slowing viral evolution
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Diane Joseph-McCarthy, Arijit Chakravarty
medRxiv 2021.04.10.21255251; doi: https://doi.org/10.1101/2021.04.10.21255251
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area